Blue Horseshoe Stocks: BIg Day for WB & More

Weibo Corp. WB – Options Recap

We decided to track WB on the heels of its earnings beat yesterday and formulated a range of call contracts that we thought would see some nice activity as a result. Post-earnings options ideas are among our favorite types of plays, and WB serves as another example of why we’re always coming back to that well.

We signaled the WB Weekly $67.50-70 Calls, and with the exception of the $68.50′s and $69′s which didn’t trade a lot of volume, we saw some killer single-session moves from the other four contracts in our highlighted range:

$67.50 Calls – Range: .70-10.78 – Max Gain: 1440%
$68 Calls – Range: 4.40-10.80 – Max Gain: 145%
$69.50 Calls – Range: 1.50-7.80 – Max Gain: 420%
$70 Calls – Range: 1.30-8.90 – Max Gain: 584%
____

Target Corp. TGT – Fresh Idea

Weibo was our fresh idea for yesterday, and today we’ve got another set of ideas to enter into the mix today with TGT.

Based purely on the look of the chart, this morning’s earnings notwithstanding, we’re attracted to the massive gap to fill to the upside, part of which has begun to fill as TGT is gapping up in the premarket.

We’re interested to follow progress on a range of both short and longer-term ideas, namely the TGT Weekly $57-59 Calls, as well as the TGT 06/23 $60-62 Calls. .


xG Technology , Inc. XGTI

We tagged XGTI for observation yesterday morning, and the stock did make a modest move of 24%, trading up from a low of 1.72 to 2.14 on the day.

While not an eye-popping move in and of itself, it did occur on massive volume, on the order of roughly 70X the 30-day average, and this morning in the premarket the stock has hit a new high of 2.19. We’ll definitely be on the lookout for a continuation of the momentum that is built up in this stock.


Extended Watchlist:
BVTK, CBIO, GNC, CETX, SNDX, TENX, TDW,

Incoming search terms:

  • bvtk -btk -bvk -investorshub
  • xgti stock

Blue Horseshoe Stocks: Bottom-Bouncers & More


North Atlantic Drilling Ltd. NADL

We’ve got an array of potential bottom-bounce plays to go over this morning, the first of which is NADL. This stock has been getting beaten down incrementally since reaching a high of 4.80 in December. It’s been one selloff after another since then, culminating in a low of .65 during yesterday’s session.

We’re seeing a moderate gap-up this morning, and want to put NADL on our watchlist moving forward on the chance that a multi-day rebound is on the way.

__________

Catalyst BioSciences, Inc. CBIO

Next up on our bottom-bounce watchlist is CBIO, which is also gapping up off of a bottom in the premarket this morning with the help of a key press release, of which we’ll include a snippet below.

The stock recently made a massive run to the $18, so the potential for another major move is certainly present.

SOUTH SAN FRANCISCO, Calif., April 11, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc., (Nasdaq:CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that it has achieved a key milestone under its collaboration with ISU Abxis to advance the Factor IX program towards its first human clinical trial. Completion of the CB 2679d/ISU304 toxicology studies supported the recent Investigational New Drug (IND) approval by the Korean Ministry of Food and Drug Safety (MFDS) and triggered a milestone payment to Catalyst. (>>View Full PR)
__________

Sunshine Heart, Inc. SSH

We tagged SSH as a bottom play a week ago today on the 4th, and subsequently tracked it over a pretty nice run last week as it traded up from 1.67 and hit 2.25 (+35%). It pulled back to the low 1.70′s yesterday and appears to be gearing up for another possible move.

Just two months ago the stock was trading at more than $5/share, so we wanted to add a little reminder this morning that SSH could be line for an extended recovery that we’ll want to look out for in the day and weeks ahead.


Galectin Therapeutics, Inc. GALT

We were just mentioning yesterday morning the excellent move from GALT we had witnessed between first bringing it up in January and the present. The run, originating at a low of .935 had already reached just beyond the 200% level, and after a very nice intraday performance, our observed range was extended even further.

Trading up from a morning low to 2.75, the stock traded up 34% to reach 3.68. That pushed the overall percentage gain we’ve witnessed in GALT for 2017 to a highly respectable 294%


Extended Watchlist:
AMLH, SALE, GLBS, AKER, STAF

Blue Horseshoe Stocks: Mid-Week Review

U.S. Stem Cell, Inc. USRM

Today marks the fourth consecutive morning that we’ve addressed USRM in our premarket report, granted the fact that it has gone on a multi-day run setting new highs one after the other.

During yesterday’s session, USRM traded in a range from .096 to .1793, a fantastic intraday swing of 87%  From the low of .014 we caught immediately following our report  on February 27th, the total increase we observed in just a shade over a month amounts to an incredible 1180%

The stock closed at .125, but the volume cooled down to just slightly more than the 30-day average. We’ll remain interested in tracking USRM as long as it can continue to build higher base levels of support.


Sunshine Heart, Inc. SSH

We tagged SSH in yesterday morning’s extended watchlist, after identifying it as a possible bottom-bouncer, and ended up providing a pretty good opportunity for a quick intraday gain which could be just the start.

The stock traded in a range from 1.67 to 2.38 for a 43% pop, and perhaps more importantly, closed with strength at 2.31 having traded more than four times the monthly average volume on the day.

That performance will have us on the lookout for a possible continuation of momentum and give SSH a chance to formulate a multi-day run.


Dollar Tree, Inc. DLTR – Options Update

We also want to give a quick update on the performances of a set of DLTR options we alerted a week ago today. The DLTR 04/21 $78-80 Calls have provided the following gain opportunities since then:

$78 Calls -  .51-1.18  (+131%)
$79 Calls – .48-.90 (+88%)
$80 Calls – .30-.61 (+103%)

The $78.50′s and the $79.50′s, also included in our highlighted range, also made commensurate gains to what’s listed above.


Extended Watchlist:
POTN, VRTX, CBIO, TNXP, RH

Blue Horseshoe Stocks: Shipping Watchlist & More

Shipping Sector Watchlist

Earlier this fall, we found an incredible amount of success within the shipping sector, as an industry-wide wave of bullish activity carried many related stocks to record moves.

That rush tuckered out a few weeks back, but we want to circle back around this morning to cast a light on several of these stocks that we think could be gearing up for a recovery. Each of the following had been in a drastic downturn leading into yesterday’s session, and each of them began to show some major signs of life in coming off their bottoms.

We’ll want to keep all of them in mind in coming sessions, and watch for signs that a more sustained uptrend could take effect.

Dry Ships, Inc. DRYS

Sino-Global Shipping America, Ltd. SINO

Diana Containerships, Inc. DCIX

Diana Shipping, Inc. DSX

Seanergy Maritime Holdings Corp. SHIP

Euroseas Ltd. ESEA

Global Ship Lease, Inc. GSL


Catalyst Biosciences, Inc. CBIO

We stipulated yesterday that if CBIO held above .80 on any early pullbacks, that we’d be interested in tracking its activity through the session, and it did just that.

The intraday machinations of the stock actually provided two separate opportunties for swing trades. First, the initial run out of the gate that took it from 1.12-1.42 (+27%) and a subsequent dip-and-rip pattern from .855 back to 1.12 later on in the day (+31%).

With volatility sufficient to provide over 50% in cumulative gains on the day, and the fact that it maintained support above our designated level, we’ll keep CBIO on our radar for the time being.


Eli Lilly and Co. LLY

On strong 2017 guidance released this week, LLY beat Wall Street’s forecast outlook estimates for the first time in 3 years. As a result, the stock started to climb, and has begun to fill a large gap on the chart to the upside.

What we want to do here is highlight both a short term and extended term options trading idea to correspond with the present situation. For swing trades this week, we’ll look at the LLY Weekly $72 and $72.50 Calls, and to take advantage of the possibility of an extended uptrend, the LLY 01/20 $75 Calls.


Extended Watchlist:
LSCG, TRUU, ERFB, TTCM, AIRW, NDEV, AXPW

Blue Horseshoe Stocks: IDXG Update & More

Interpace Diagnostics Group, Inc. IDXG

We tracked IDXG last week over a couple of stellar sessions that led to a swing of more than 400%, cautioning that a dip-and-rip could be in the cards after seeing such a volatile move to the upside.

That’s exactly what we’ve seen in the past couple of days, as IDXG came down to find support at the .865 level, and in the ensuing three sessions it’s been steadily registering higher highs and higher lows, getting back to 1.25 yesterday (+45%).

We’ll continue to follow this story, which kicked off with the revelation that Aetna would cover Interpace’s ThyraMir™ test for its 46 million insured members. (>>View PR)


Experience Art & Design, Inc. EXAD

We had EXAD tagged in yesterday’s premarket report and this subpenny play produced a moderate run to kick off the session, even as the larger markets were struggling with the Fed rate hike announcement.

From an early low of .0023, the stock took just the first hour of trading to find its way up to a high of .0038, for a 65% pop. IDXG hung around that level until around lunchtime, and it did come back down to its daily low toward the close, so we’ll be looking for the possibility of a rebound.


Catalyst Biosciences, Inc. CBIO

We’re also interested in following the activity of CBIO today, which is gapping up in the premarket to the tune of more than 100% and looks like it could be lining up to have a big day. We’ll want to make sure it holds above its 50DMA (.80) on any pullbacks, but if it can breach past its 200DMA of 1.31, things could get very interesting.

News broke yesterday via an 8-K filing that CBIO had entered into a definitive agreement with Wyeth LLC, (wholly-owned subsidiary of Pfizer Inc.) to transfer exclusive rights to research, develop, manufacture and commercialize Factor VIIa variants, CB 813a and CB 813d, as well as transferring the investigational NDA to CBIO as well. (>>View Filing)



Fresh Options Idea: 
Transocean, Inc. RIG $15 and $14.50 Puts


Extended Watchlist:
VCEL, NWBO, BCLI, BPMX, DLOV, PPMT

Incoming search terms:

  • nwBo moves